Hormonal changes and weight changes often show up at the same time, and in some cases, they may be related. A woman going through menopause may notice that weight is settling differently around her midsection, even when her habits have not changed significantly. A man with low testosterone may notice declining strength, less muscle mass, or more body fat. Hormonal changes can also affect factors such as energy, sleep, and physical activity, which may indirectly make weight management more difficult even when the hormonal changes themselves are not directly causing weight gain. Any of these people may be struggling with excess weight that has become difficult to manage through lifestyle changes alone.
This overlap is one reason hormone replacement therapy (HRT) and GLP-1 medications are sometimes discussed as part of the same treatment plan.
HRT and GLP-1 medications can be prescribed together when a patient is an appropriate candidate for each. They do different things, however, and neither treatment should be prescribed simply to make the other “more effective”.
At Fountain of You MD, our providers look at hormone health, body composition, metabolic health, symptoms, lab results, and treatment goals to determine what is actually contributing to the patient’s concerns. For some patients, that may lead to HRT. For others, a GLP-1 medication may be the appropriate treatment. Some patients may benefit from both.
What HRT and GLP-1 Medications Each Do
HRT is used to treat an appropriately diagnosed hormone deficiency or address symptoms associated with hormonal changes when treatment is clinically appropriate. The specific hormones used depend on the patient.
For women, a treatment plan may include estrogen, progesterone, and/or testosterone based on symptoms, lab results, and health history. Treatment is often used to address menopause symptoms such as hot flashes and night sweats, although hormone changes can also affect things such as sleep, energy, bone health, libido, and body composition, and may happen well before menopause.
For men, testosterone replacement therapy (TRT) may help address symptoms such as low energy, reduced libido, decreased strength, difficulty concentrating, and changes in body composition related to lean mass, fat mass, muscle size, and strength.
GLP-1–based medications such as semaglutide and tirzepatide work differently. They affect pathways involved in appetite, fullness, blood sugar regulation, and digestion. In medical weight management, these effects can reduce hunger and make it easier to maintain the calorie deficit necessary for weight loss.
This distinction is important because HRT is not a substitute for medical weight management, and a GLP-1 medication does not correct an underlying hormone deficiency. When both are appropriate, however, they may address different factors influencing overlapping symptoms related to how a patient feels, functions, and responds to changes in weight and body composition.
Hormones, Midsection Weight, and Body Composition
One of the most frustrating changes women report around menopause is an increase in abdominal or midsection fat. This is not simply a matter of getting older or “slowing metabolism.” Menopause is associated with changes in body composition and a greater tendency for fat to accumulate centrally, including around the abdomen. Estrogen appears to play a role in how fat is distributed throughout the body.
While research has not consistently shown that hormone therapy produces significant overall weight loss, there is evidence that hormone therapy may help mitigate some of the unfavorable changes in fat distribution that occur after menopause. For example, clinical research has found less upper-body fat accumulation and better preservation of lean tissue in some postmenopausal women receiving hormone therapy compared with placebo. Other research has found that estrogen-containing therapy may help limit increases in abdominal fat.
For an appropriate candidate, this creates an important distinction: the goal of HRT is not to simply make the number on the scale drop. It may, however, be one part of addressing the hormonal changes occurring alongside a shift in body composition.
A GLP-1 medication approaches the problem from another direction. By reducing appetite and supporting meaningful weight loss, it can help reduce overall fat mass. For a woman who has both bothersome menopause symptoms and a medical indication for weight management, addressing both concerns may make more sense than assuming every symptom or body-composition change has the same cause.
TRT, Muscle Mass, and GLP-1 Weight Loss
The relationship between testosterone, muscle, and weight management is particularly important for men. Testosterone plays an important role in maintaining skeletal muscle. In men with hypogonadism, research has consistently found that testosterone replacement can increase lean body mass. Clinical studies have also demonstrated increases in muscle size and, in some cases, strength when testosterone deficiency is appropriately treated.
For a man who has low testosterone, restoring testosterone can be relevant to a larger body-composition plan. This becomes especially important during significant weight loss.
When someone loses weight, the weight lost is not exclusively body fat. Some lean tissue is typically lost as well. In a body-composition substudy of the SURMOUNT-1 trial, approximately 75% of the weight lost with tirzepatide came from fat mass and approximately 25% from lean mass.
That does not mean GLP-1 medications inherently “cause muscle wasting.” Lean mass commonly decreases during substantial weight loss regardless of the method used. It does mean that preserving muscle deserves attention throughout treatment.
For men with testosterone deficiency who are also appropriate candidates for a GLP-1 medication, treating the testosterone deficiency may support a healthier body-composition environment while weight is coming down. However, TRT should not be viewed as a guarantee against lean-mass loss, as adequate protein, resistance training, an appropriate rate of weight loss, and ongoing monitoring remain essential.
Can HRT Make GLP-1 Medications Work Better?
This is an interesting area of emerging research, particularly for women after menopause.
A retrospective study published in 2024 compared postmenopausal women taking semaglutide for overweight or obesity based on whether they were also using menopause hormone therapy. Women using hormone therapy experienced greater average total body weight loss at 3, 6, 9, and 12 months. At 12 months, average weight loss was approximately 16% among hormone therapy users compared with 12% among women who were not using hormone therapy.
While the findings are promising, the study was small and observational, with only 16 women in the hormone therapy group. More research is needed before we can conclude that HRT makes semaglutide more effective. Still, the results suggest a potential relationship between hormone therapy and weight-loss response that warrants further study.
Potential Benefits When Both Treatments Are Appropriate
The potential value of using HRT and a GLP-1 medication together is less about one medication “boosting” the other and more about addressing the full clinical picture.
When a patient is an appropriate candidate for both treatments, using HRT and a GLP-1 medication together may provide a more complete approach than addressing only one concern. HRT can target symptoms related to a documented hormone imbalance, while a GLP-1 medication can support appetite regulation and medical weight loss.
Potential benefits of a carefully monitored combination may include:
- Improved energy, sleep, mood, libido, or recovery as hormone-related symptoms are addressed
- Reduced hunger and food noise, making it easier to follow a consistent nutrition plan
- Better support for healthy body composition when treatment is paired with adequate protein intake and resistance training
- Greater ability to stay active and maintain healthy habits as the patient begins feeling better
- A more comprehensive treatment plan for patients whose hormone health and weight-related concerns are affecting one another
Each treatment can address a different part of the patient’s health at the same time. When both are clinically appropriate, this may help the patient feel better, manage appetite more effectively, and make sustainable progress toward improved health and body-composition goals.
Is It Safe to Take HRT and a GLP-1 Together?
There is no blanket rule that prevents HRT and a GLP-1 medication from being used together. The more important question is whether the patient is an appropriate candidate for each treatment individually.
Before prescribing, a provider should review the patient’s medical history, current medications, symptoms, lab results, weight history, metabolic health, and treatment goals.
Depending on the therapies being considered, that evaluation may include:
- Personal and family medical history
- Current prescriptions, supplements, and prior treatment response
- Hormone-related symptoms and lab results
- Weight history, blood pressure, blood sugar, and other metabolic markers
- Pregnancy plans and contraceptive needs
- History of pancreatitis, gallbladder problems, severe gastrointestinal disease, or certain thyroid cancers
- Cancer history, cardiovascular risk, fertility goals, sleep apnea, hematocrit, and prostate-related factors when relevant
This is also why medical supervision matters. Candidacy for HRT does not automatically establish candidacy for a GLP-1 medication, and vice versa. A knowledgeable provider should be able to explain what qualifies you for each treatment, which risks apply to you, what will be measured, and why the timing makes sense.
Why We May Start One Treatment Before the Other
Even when a patient is a candidate for both treatments, starting everything on the same day is not typically the recommended approach.
Dr. Jeffrey Arbuckle’s general clinical preference at Fountain of You MD is to address a clear hormone issue first when appropriate, allow the patient to begin responding to treatment, and then consider adding a GLP-1 medication approximately six to eight weeks later if medical weight loss remains an appropriate goal. In certain instances, we may start a patient on a weight loss treatment plan and then add on the hormone therapy.
The reason for this is that if a patient begins multiple therapies simultaneously and suddenly feels better, experiences nausea, notices an appetite change, sleeps differently, or sees a change in energy or exercise performance, it can be difficult to know which treatment is responsible. Sequencing treatment gives the provider a clearer picture.
It may also give patients time to establish habits that become increasingly important once weight loss begins. If treating a hormone deficiency improves a patient’s ability to exercise, recover, sleep, or maintain activity, that can provide a stronger foundation for protecting muscle during weight loss.
This six-to-eight-week approach is a clinical strategy sometimes used by our practice, not a universal requirement or established guideline for combining HRT with GLP-1 medications. Not every patient needs to follow the same sequence.
When Starting Both Closer Together May Make Sense
A provider may combine treatments sooner when the patient has already been stable on HRT, has used one of the therapies before without difficulty, or has a weight-related health concern that should not be unnecessarily delayed. The decision may also change when symptoms are mild, lab findings are straightforward, and the patient has no major tolerability concerns.
The decision comes down to the patient’s health, treatment history, symptoms, goals, and the provider’s ability to safely monitor both therapies.
What Monitoring Looks Like
Monitoring should follow both sides of the treatment plan rather than focusing only on the number on the scale.
For hormone therapy, monitoring may include:
- Symptoms, treatment response, and side effects
- Follow-up hormone levels and other labs based on the patient and therapy
- Blood pressure and changes in bleeding patterns when relevant
- Hemoglobin and hematocrit for patients using testosterone
- PSA or prostate follow-up when appropriate
For GLP-1 treatment, monitoring may include:
- Weight trend, waist changes, appetite, and food intake
- Nausea, constipation, diarrhea, reflux, or other digestive symptoms
- Hydration and the ability to consume adequate protein and nutrients
- Signs of gallbladder problems, pancreatitis, or other serious adverse effects
- Dose tolerance before any increase is considered
When both treatments are used, providers should also watch body composition and strength. GLP-1–assisted weight loss can include loss of lean mass, particularly when protein intake and resistance training are inadequate. HRT does not eliminate that risk. A complete plan still needs adequate nutrition, strength-focused movement, and a dose that supports steady progress without making it difficult to eat or hydrate.
When a Provider May Recommend Waiting or Choosing One Treatment Instead
Having hormone-related symptoms and difficulty losing weight does not automatically mean a patient needs both treatments. Sometimes the evaluation points strongly in one direction.
A provider may delay or avoid one or both treatments when the medical history raises a safety concern, required testing has not been completed, pregnancy is planned, medication contraindications, or the patient is unable to maintain adequate nutrition and hydration.
At Fountain of You MD, the objective is not to put every patient on HRT and a GLP-1 medication. It is to determine which concerns require treatment and build the plan accordingly in a way that works best for the individual patient.
HRT and GLP-1 Treatment at Fountain of You MD
HRT and GLP-1 medications do not need to compete for the same role in a treatment plan. For the right patient, they may address different factors contributing to symptoms, weight, and body composition. The important part is determining whether there is a medical reason for each treatment.
If you are experiencing hormone-related symptoms, changes in body composition, or difficulty reaching a healthy weight, schedule a consultation at our Virginia Beach or Chesapeake office. If needed, we will arrange lab testing before your visit. During your consultation, your provider will review your symptoms, medical history, lab results, and goals to determine which treatment options may be appropriate for you.
Frequently Asked Questions
Does HRT help with menopause belly fat?
HRT is not a weight-loss treatment, but menopause hormone therapy may influence body composition and fat distribution. Menopause is associated with an increase in central or abdominal fat, and some research suggests hormone therapy may help limit this shift in appropriately selected women. Diet, physical activity, sleep, genetics, age, and overall metabolic health still play important roles in weight and body composition.
Does HRT cause weight loss?
HRT should not be prescribed with the expectation that it will produce significant weight loss. Its primary purpose is to treat appropriate hormone-related symptoms and conditions. Some patients may notice changes in body composition or find it easier to maintain healthy habits as symptoms improve, but results vary.
Can hormone therapy make semaglutide more effective?
Potentially. One retrospective study found greater weight loss among postmenopausal women taking both semaglutide and menopause hormone therapy compared with women taking semaglutide without hormone therapy. Because the study was small and observational, it cannot prove that hormone therapy was responsible for the difference. More research is needed.
Can TRT help build muscle while taking a GLP-1?
Testosterone replacement has been shown to increase lean body mass and can improve muscle size and strength. That may be particularly relevant during weight loss, when preserving lean tissue is important. However, TRT cannot guarantee that a patient will not lose lean mass while taking a GLP-1 medication. Resistance training and adequate protein intake remain important.
Will a GLP-1 fix a hormone imbalance?
No. GLP-1 medications can support weight loss and metabolic health, but they do not replace estrogen, progesterone, or testosterone when hormone therapy is otherwise clinically indicated.
Can HRT prevent muscle loss during GLP-1 weight loss?
Appropriate hormone treatment may support energy, strength, and body composition in a patient who has a documented hormone deficiency, but it should not be presented as guaranteed protection against muscle loss. Protein intake, resistance training, an appropriate rate of weight loss, and ongoing monitoring remain essential.
